Trial intelligence / Profile preview

Extended-release vs Immediate-release Metformin in PCOS

NCT02984722Unknown

Sponsor
Università Cattolica del Sacro Cuore
Start
Dec 2016
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Gastrointestinal disorders at 6 months. Status: unknown.

02

Drugs

metformin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02984722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02984722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call